Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 300, Issue 5, 2011, Pages

  Kannan, Kolenkode B ^a   Colorado, Iriana ^a   Reino, Diego ^a   Palange, David ^a   Lu, Qi ^a   Qin, Xiaofa ^a   Abungu, Billy ^a   Watkins, Anthony ^a   Caputo, Francis J ^a   Xu, Da Zhong ^a   Semenza, Gregg L ^b   Deitch, Edwin A ^a   Feinman, Rena ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inducible nitric oxide synthase; Inflammation; Mucosal injury

Indexed keywords

CASPASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION;

ACUTE LUNG INJURY; ANIMALS; BLOTTING, WESTERN; CASPASE 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HYPOXIA-INDUCIBLE FACTOR 1; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINES; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PERMEABILITY; PEROXIDASE; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79955562849     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00459.2010     Document Type: Article

References (56)

1. Banafsche R, Gunther L, Nefflen JU, Moutsiou S, Knolle PA, Herfarth C, Klar E. NF-κB antisense oligonucleotides reduce leukocyteendothelial interaction in hepatic ischemia-reperfusion. Transplant Proc 33: 3726-3727, 2001.
2. Chaitanya GV, Babu PP. Activation of calpain, cathepsin-B and caspase-3 during transient focal cerebral ischemia in rat model. Neurochem Res 33: 2178-2186, 2008.
3. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 9: 575-581, 2003.
4. Chen Y, Lui VCH, Rooijen NV, Tam PKH. Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut. Gut 53: 1772-1780, 2004.
5. Chiu C, McArdle A, Brown R, Scott H, Gurd F. Intestinal mucosal lesions in low-flow states. Arch Surg 101: 478-483, 1970.
6. Clark J, Coopersmith C. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 28: 384-393, 2007.
7. Colgan SP, Taylor CT. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7: 281-287, 2010.
8. Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, Taylor CT. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165, 2008.
9. Dehne N, Brüne B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 315: 1791-1797, 2009.
10. Deitch EA, Sambol JT. The Gut-Origin Hypothesis of MODS. Baltimore: W. B. Saunders, 2002, p. 105-116.
11. Deitch EA, Shorshtein A, Houghton J, Lu Q, Xu DZ. Inducible nitric oxide synthase knockout mice are resistant to diet-induced loss of gut barrier function and intestinal injury. J Gastrointest Surg 6: 599-605, 2002.
12. Deitch EA, Xu D, Lu Q. Gut lymph hypothesis of early shock and trauma-induced multiple organ dysfunction: A new look at gut origin of sepsis. J Org Dys 2: 70-70, 2006.
13. Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, Zhang R, Gross GJ, Falck JR, Patel PK, Jacobs ER, Medhora M. Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol 294: H724-H735, 2008.
14. Erickson S, Martin G, Davis J, Matthay M, Eisner M. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 37: 1574-1579, 2009.
15. Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, Kannan KB, Sheth S, Caputo FJ, Lu Q, Ramanathan M, Attan S, Badami CJ, Doucet D, Barlos D, Bosch-Marce M, Semenza GL, Xu DZ. HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 299: G833-G843, 2010.
16. Fink MP, Delude RL. Epithelial barrier dysfunction: A unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin.
17. Forsythe RM, Xu DZ, Lu Q, Deitch EA. LPS-induced enterocytederived nitric oxide induces intestinal monolayer permeability in an autocrine fashion. Shock 17: 180-184, 2002.
18. Giakoustidis AE, Giakoustidis DE, Koliakou K, Kaldrymidou E, Iliadis S, Antoniadis N, Kontos N, Papanikolaou V, Papageorgiou G, Atmatzidis K, Takoudas D. Inhibition of intestinal ischemia/repurfusion induced apoptosis and necrosis via down-regulation of the NF-κB, c-Jun and caspase-3 expression by epigallocatechin-3-gallate administration. Free Radic Res 42: 180-188, 2008.
19. Guan Y, Worrell RT, Pritts TA, Montrose MH. Intestinal ischemiareperfusion injury: reversible and irreversible damage imaged in vivo. Am J Physiol Gastrointest Liver Physiol 297: G187-G196, 2009.
20. Hart ML, Henn M, Kohler D, Kloor D, Mittelbronn M, Gorzolla IC, Stahl GL, Eltzschig HK. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 22: 2784-2797, 2008.
21. Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK. Cutting edge: A2B adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 182: 3965-3968, 2009.
22. Hierholzer C, Harbrecht BG, Billiar TR, Tweardy DJ. Hypoxiainducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events. Arch Orthop Trauma Surg 121: 219-222, 2001.
23. Hirota SA, Fines K, Ng J, Traboulsi D, Lee J, Ihara E, Li Y, Willmore WG, Chung D, Scully MM, Louie T, Medlicott S, Lejeune M, Chadee K, Armstrong G, Colgan SP, Muruve DA, MacDonald JA, Beck PL. Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology 139: 259-269. e3, 2010.
24. Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, Hammond R, Gimotty PA, Keith B, Simon MC. Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 120: 2699-2714, 2010.
25. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12: 149-162, 1998.
26. Kan WH, Hsu JT, Schwacha MG, Choudhry MA, Raju R, Bland KI, Chaudry IH. Selective inhibition of iNOS attenuates trauma-hemorrhage/ resuscitation-induced hepatic injury. J Appl Physiol 105: 1076-1082, 2008.
27. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114: 1098-1106, 2004.
28. Kiang JG, Bowman PD, Lu X, Li Y, Wu BW, Loh HH, Tsen KT, Tsokos GC. Geldanamycin inhibits hemorrhage-induced increases in caspase-3 activity: role of inducible nitric oxide synthase. J Appl Physiol 103: 1045-1055, 2007.
29. Kiang JG, Peckham RM, Duke LE, Shimizu T, Chaudry IH, Tsokos GC. Androstenediol inhibits the trauma-hemorrhage-induced increase in caspase-3 by downregulating the inducible nitric oxide synthase pathway. J Appl Physiol 102: 933-941, 2007.
30. Koury J, Deitch EA, Homma H, Abungu B, Gangurde P, Condon MR, Lu Q, Xu DZ, Feinman R. Persistent HIF-1α activation in gut ischemia/ reperfusion injury: potential role of bacteria and lipopolysaccharide. Shock 22: 270-277, 2004.
31. Liaudet L, Szabo A, Soriano F, Zingarelli B, Szabo C, Salzman A. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 14: 142-143, 2000.
32. Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Molecular Cell 40: 294-309, 2010.
33. Matrone C, Pignataro G, Molinaro P, Irace C, Scorziello A, Di Renzo GF, Annunziato L. HIF-1 reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J Neurochem 90: 368-378, 2004.
34. Melillo G, Taylor LS, Brooks A, Musso T, Cox GW, Varesio L. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem 272: 12236-12243, 1997.
35. Michalsky MP, Deitch EA, Ding J, Lu Q, Huang Q. Interleukin-6 and tumor necrosis factor production in an enterocyte cell model (Caco-2) during exposure to Escherichia coli. Shock 7: 139-146, 1997.
36. Murao Y, Loomis W, Wolf P, Hoyt DB, Junger WG. Effect of dose of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock. Shock 20: 29-34, 2003.
37. Noda T, Iwakiri R, Fujimoto K, Matsuo S, Aw T. Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol Gastrointest Liver Physiol 274: G270-G276, 1998.
38. Palmer LA, Semenza GL, Stoler MH, Johns RA. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol Lung Cell Mol Physiol 274: L212-L219, 1998.
39. Patel NJ, Zaborina O, Wu L, Wang Y, Wolfgeher DJ, Valuckaite V, Ciancio MJ, Kohler JE, Shevchenko O, Colgan SP, Chang EB, Turner JR, Alverdy JC. Recognition of intestinal epithelial HIF-1α activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol 292: G134-G142, 2007.
40. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR. Heterozygous HIF1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577: 705-716, 2006.
41. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V. Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J Immunol 178: 7516-7519, 2007.
42. Pfaffl M. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45, 2001.
43. Robinson A, Keely S, Karhausen J, Gerich ME, Furuta GT, Colgan SP. Mucosal protection by hypoxia-inducible factor (HIF) prolyl hydroxylase inhibition. Gastroenterology 134: 144-155, 2008.
44. Rupani B, Caputo F, Watkins A, Vega D, Magnotti L, Lu Q, Xu D, Deitch E. Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 141: 481-489, 2007.
45. Sasaki M, Joh T. Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr 40: 1-12, 2007.
46. Scharte M, Han X, Bertges DJ, Fink MP, Delude RL. Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am J Physiol Gastrointest Liver Physiol 284: G373-G384, 2003.
47. Scharte M, Han X, Uchiyama T, Tawadrous Z, Delude RL, Fink MP. LPS Increases hepatic HIF-1α protein and expression of the HIF-1-dependent gene aldolase A in rats. J Surg Res 135: 262-267, 2006.
48. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 91: 803-806, 2006.
49. Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134: 2036-2048, e2033, 2048.e1-3, 2008.
50. Suzuki Y, Deitch EA, Mishima S, Lu Q, Xu DZ. Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med 28: 3692-3696, 2000.
51. Taylor C, Colgan S. Hypoxia and gastrointestinal disease. J Mol Med 85: 1295-1300, 2007.
52. Van Hoecke M, Pringent-Tessier A, Garnier P, Bertrand N, Filomenko R, Bettaieb A, Marie C, Beley A. Evidence of HIF-1 functional binding activity to caspase-3 promoter after photothrombotic cerebral ischemia. Mol Cell Neurosci 34: 40-47, 2007.
53. Vangeison G, Carr D, Federoff HJ, Rempe DA. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1α in neurons and astrocytes. J Neurosci 28: 1988-1993, 2008.
54. Xu DZ, Lu Q, Deitch EA. Nitric oxide directly impairs intestinal barrier function. Shock 17: 139-145, 2002.
55. Yeh KY, Yeh M, Glass J, Granger DN. Rapid activation of NF-κB and AP-1 and target gene expression in postischemic rat intestine. Gastroenterology 118: 525-534, 2000.
56. Yu HP, Hsieh YC, Suzuki T, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH. Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: upregulation of the PI-3K/Akt pathway. J Leukoc Biol 82: 774-780, 2007.